Showing 1 - 20 results of 36 for search 'Bart N. M. van Berckel', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions by Jorge Jovicich, Frederik Barkhof, Claudio Babiloni, Karl Herholz, Christoph Mulert, Bart N.M. vanBerckel, Giovanni B. Frisoni, SRA‐NED JPND Working Group
Published 2019-12-01
Article -
5
Physical activity levels in cognitively normal and cognitively impaired oldest-old and the association with dementia risk factors: a pilot study by Marijn Muurling, Maryam Badissi, Casper de Boer, Nienke Legdeur, Frederik Barkhof, Bart N.M. van Berckel, Andrea B. Maier, Mirjam Pijnappels, Pieter Jelle Visser
Published 2023-03-01
Article -
6
Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals by Lyduine E. Collij, Sophie E. Mastenbroek, Gemma Salvadó, Alle Meije Wink, Pieter Jelle Visser, Frederik Barkhof, Bart. N.M. vanBerckel, Isadora Lopes Alves
Published 2021-01-01
Article -
7
Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status by Eline A. J. Willemse, Betty M. Tijms, Bart N. M. vanBerckel, Nathalie Le Bastard, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
Published 2021-01-01
Article -
8
Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline by Hayel Tuncel, Denise Visser, Tessa Timmers, Emma E. Wolters, Rik Ossenkoppele, Wiesje M. van der Flier, Bart N. M. van Berckel, Ronald Boellaard, Sandeep S. V. Golla
Published 2023-10-01
Article -
9
-
10
Contralateral improvement of cerebrovascular reactivity and TIA frequency after unilateral revascularization surgery in moyamoya vasculopathy by Pieter T. Deckers, Wytse van Hoek, Annick Kronenburg, Maqsood Yaqub, Jeroen C.W. Siero, Alex A. Bhogal, Bart N.M. van Berckel, Albert van der Zwan, Kees P.J. Braun
Published 2021-01-01
Article -
11
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences by Arno de Wilde, Juhan Reimand, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Femke Bouwman, Rik Ossenkoppele
Published 2019-09-01
Article -
12
Added value of amyloid PET in individualized risk predictions for MCI patients by Ingrid S. vanMaurik, Laura M. van derKall, Arno deWilde, Femke H. Bouwman, Philip Scheltens, Bart N.M. vanBerckel, Johannes Berkhof, Wiesje M. van derFlier, Alzheimer's Disease Neuroimaging Initiative
Published 2019-12-01
Article -
13
Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old by Wiesje Pelkmans, Nienke Legdeur, Mara tenKate, Frederik Barkhof, Maqsood M. Yaqub, Henne Holstege, Bart N. M. vanBerckel, Philip Scheltens, Wiesje M. van derFlier, Pieter Jelle Visser, Betty M. Tijms
Published 2021-02-01
Article -
14
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum by Tessa Timmers, Rik Ossenkoppele, Emma E. Wolters, Sander C. J. Verfaillie, Denise Visser, Sandeep S. V. Golla, Frederik Barkhof, Philip Scheltens, Ronald Boellaard, Wiesje M. van der Flier, Bart N. M. van Berckel
Published 2019-07-01
Article -
15
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases by Juhan Reimand, Arno de Wilde, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Rik Ossenkoppele, Femke Bouwman
Published 2019-12-01
Article -
16
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status by Rosha Babapour Mofrad, Philip Scheltens, SangYun Kim, Sungmin Kang, Young Chul Youn, Seong Soo A. An, Jori Tomassen, Bart N. M. van Berckel, Pieter Jelle Visser, Wiesje M. van der Flier, Charlotte E. Teunissen
Published 2021-07-01
Article -
17
A longitudinal study on quality of life along the spectrum of Alzheimer’s disease by Arenda Mank, Judith J. M. Rijnhart, Ingrid S. van Maurik, Linus Jönsson, Ron Handels, Els D. Bakker, Charlotte E. Teunissen, Bart N. M. van Berckel, Argonde C. van Harten, Johannes Berkhof, Wiesje M. van der Flier
Published 2022-09-01
Article -
18
Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[3H]3methoxy phenyl)‐N′‐methylguanidine ([3H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagon... by Athanasios Metaxas, Bart N. M. van Berckel, Pieter J. Klein, Joost Verbeek, Emily C. Nash, Esther J. M. Kooijman, Véronique A. Renjaän, Sandeep S. V. Golla, Ronald Boellaard, Johannes A. M. Christiaans, Albert D. Windhorst, Josée E. Leysen
Published 2019-02-01
Article -
19
Longitudinal change in ATN biomarkers in cognitively normal individuals by Jarith L. Ebenau, Denise Visser, Lior A. Kroeze, Mardou S. S. A. van Leeuwenstijn, Argonde C. van Harten, Albert D. Windhorst, Sandeep V. S. Golla, Ronald Boellaard, Philip Scheltens, Frederik Barkhof, Bart N. M. van Berckel, Wiesje M. van der Flier
Published 2022-09-01
Article -
20
Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex by Marie-Paule E. van Engelen, Sander C. J. Verfaillie, Annemieke Dols, Mardien L. Oudega, Ronald Boellaard, Sandeep S. V. Golla, Marijke den Hollander, Rik Ossenkoppele, Philip Scheltens, Bart N. M. van Berckel, Yolande A. L. Pijnenburg, Everard G. B. Vijverberg
Published 2023-07-01
Article